SVB Leerink Downgrades Aptinyx to Market Perform, Announces $0.5 Price Target
H.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)
SVB Securities Keeps Their Buy Rating on Aptinyx (APTX)
BMO Capital Remains a Buy on Aptinyx (APTX)
Aptinyx Is Maintained at Buy by HC Wainwright & Co.
Aptinyx Price Target Cut to $1.00/Share From $2.00 by HC Wainwright & Co.
HC Wainwright Adjusts Price Target on Aptinyx to $1 From $2, Reiterates Buy Rating
Aptinyx Analyst Ratings
Aptinyx Cut to Market Perform From Outperform by Cowen & Co.
Aptinyx Cut to Hold From Buy by Truist Securities
Aptinyx Analyst Ratings
What 4 Analyst Ratings Have To Say About Aptinyx
Aptinyx Price Target Cut to $2.00/Share From $6.00 by BMO Capital
Aptinyx Is Maintained at Outperform by BMO Capital
Aptinyx Analyst Ratings
BMO Capital Maintains Outperform on Aptinyx, Lowers Price Target to $2
Aptinyx Cut to Neutral From Overweight by Piper Sandler
Aptinyx Price Target Cut to $2.00/Share From $6.00 by Piper Sandler
Aptinyx analyst ratings
Piper Sandler Downgrades Aptinyx to Neutral, Lowers Price Target to $2
No Data